Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease

Digestive and Liver Disease

Volumn 42, Issue 8, 2010, Pages 544-548

  Da Silva, Nancy ^a   Arasaradnam, Ramesh ^a,b   Getliffe, Katherine ^a   Sung, Edward ^b   Oo, Ye ^b   Nwokolo, Chuka ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

Author keywords

Crohn's disease; Peripheral blood mononuclear cells; Telomere binding proteins; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; MESALAZINE; MESSENGER RNA; PHYTOHEMAGGLUTININ; POT1 PROTEIN; RAP1 PROTEIN; TELOMERE BINDING PROTEIN; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; TPP1 PROTEIN; UNCLASSIFIED DRUG; POT1 PROTEIN, HUMAN; PTOP PROTEIN, HUMAN; TERF2IP PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE DURATION; DOWN REGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS; BIOSYNTHESIS; BLOOD; CHROMOSOMAL INSTABILITY; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; COMPLICATION; DRUG EFFECTS; GENETICS; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE; TELOMERE; ULTRASTRUCTURE;

AZATHIOPRINE; CHROMOSOMAL INSTABILITY; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; CROHN DISEASE; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MESALAMINE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; TELOMERE; TELOMERE-BINDING PROTEINS; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2; TUMOR MARKERS, BIOLOGICAL;

EID: 77954424254     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.12.005     Document Type: Article

References (29)

1. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3:521-533.
2. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990, 323:1228-1233.
3. Loeb K.R., Loeb L.A. Genetic instability and the mutator phenotype. Studies in ulcerative colitis. Am J Pathol 1999, 154:1621-1626.
4. O'Sullivan J.N., Bronner M.P., Brentnall T.A., et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002, 32:280-284.
5. Cottliar A., Fundia A., Boerr L., et al. High frequencies of telomeric associations, chromosome aberrations, and sister chromatid exchanges in ulcerative colitis. Am J Gastroenterol 2000, 95:2301-2307.
6. Bonassi S., Abbondandolo A., Camurri L., et al. Are chromosome aberrations in circulating mononuclears predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 1995, 79:133-135.
7. Blackburn E.H. Switching, and signalling at the telomere. Cell 2001, 106:661-673.
8. de Lange T. Protection of mammalian telomeres. Oncogene 2002, 21:532-540.
9. Karlseder J. Telomere repeat binding factors: keeping the ends in check. Cancer Lett 2003, 194:189-197.
10. Lee H.W., Blasco M.A., Gottlieb G.J., et al. Essential role of mouse telomerase in highly proliferative organs. Nature 1998, 392:569-574.
11. Getliffe K.M., Al Dulaimi D., Martin-Ruiz C., et al. Mononuclear telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking. Aliment Pharmacol Ther 2005, 21:121-131.
12. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005, 19:2100-2110.
13. Stansel R.M., de Lange T., Griffith J.D. T-loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang. Embo J 2001, 20:5532-5540.
14. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92:401-413.
15. Bradshaw P.S., Stavropoulos D.J., Meyn M.S. Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage. Nat Genet 2005, 37:193-197.
16. Dantzer F., Giraud-Panis M.J., Jaco I., et al. Functional interaction between poly(ADP-ribose) polymerase 2 (PARP-2) and TRF2: PARP activity negatively regulates TRF2. Mol Cell Biol 2004, 24:1595-1607.
17. Fotiadou P., Henegariu O., Sweasy J.B. DNA polymerase beta interacts with TRF2 and induces telomere dysfunction in a murine mammary cell line. Cancer Res 2004, 64:3830-3837.
18. Harvey R.F., Bradshaw J.M. A simple index of Crohn's-disease activity. Lancet 1980, 1:514.
19. Freshney R. Culture of animal cells: a manual of basic technique 1987, Alan R. Liss, Inc., New York, p. 117.
20. Yamada K., Yagihashi A., Yamada M., et al. Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells. Anticancer Res 2002, 22:1315-1320.
21. Rabinovitch P.S., Dziadon S., Brentnall T.A., et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999, 59:5148-5153.
22. Askling J., Brandt L., Lapidus A., et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 2005, 54:617-622.
23. Johnstone A.P., Williams G.T. Role of DNA breaks and ADP-ribosyl transferase activity in eukaryotic differentiation demonstrated in human mononuclears. Nature 1982, 300:368-370.
24. Boerrigter M.E., Vijg J. Single-strand break disappearance in quiescent and phytohaemagglutinin-stimulated human peripheral blood mononuclears exposed to a single low dose of gamma-radiation. Int J Radiat Biol 1992, 61:95-101.
25. O'Connor M., Safari A., Xin H., et al. A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly. PNAS 2006, 103:11874-11879.
26. Risques R.A., Lai L.A., Brentall T.A., et al. Ulcerative Colitis is a disease of accelerated colon ageing: evidence of from telomere attrition and DNA damage. Gastroenterology 2008, 135:410-418.
27. Arasaradnam R.P., Khoo K.T., Bardburn M., et al. Telomere attrition in colorectal mucosa of patients with ulcerative colitis (abs). Gut 2009, A100-257.
28. Colgin L., Reddel R., Telomere Biology: A new player in the End Zone. Curr Biol 2004, 14:901-902.
29. Rubin D.T., LoSavio A., Yadron N., et al. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Clin Gastroenterol Hepatol 2006, 4:1346-1350.